106 related articles for article (PubMed ID: 33301809)
1. Identification of molecular mechanisms for achieving HIV-1 control in the absence of antiretroviral therapy.
Hu X; Ni Y; Wang F; Ni Z; Jin T; Li Y; Ni M
Life Sci; 2021 Jan; 265():118857. PubMed ID: 33301809
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation.
Noel N; Peña R; David A; Avettand-Fenoel V; Erkizia I; Jimenez E; Lecuroux C; Rouzioux C; Boufassa F; Pancino G; Venet A; Van Lint C; Martinez-Picado J; Lambotte O; Sáez-Cirión A; Prado JG
J Virol; 2016 Jul; 90(13):6148-6158. PubMed ID: 27122576
[TBL] [Abstract][Full Text] [Related]
3. Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.
Chereau F; Madec Y; Sabin C; Obel N; Ruiz-Mateos E; Chrysos G; Fidler S; Lehmann C; Zangerle R; Wittkop L; Reiss P; Hamouda O; Estrada Perez V; Leal M; Mocroft A; Garcia De Olalla P; Ammassari A; D'Arminio Monforte A; Mussini C; Segura F; Castagna A; Cavassini M; Grabar S; Morlat P; De Wit S; Lambotte O; Meyer L;
PLoS One; 2017; 12(4):e0173893. PubMed ID: 28380038
[TBL] [Abstract][Full Text] [Related]
4. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
[TBL] [Abstract][Full Text] [Related]
5. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
6. The proportion of CD57+ cells among effector CD8+ T cells is lower in HIV controllers compared with antiretroviral therapy-treated patients.
Henriquez S; Lécuroux C; Bitu M; Avettand-Fenoel V; Churaqui F; Catalan P; Chéret A; Boufassa F; Saez-Cirion A; Monceaux V; Meyer L; Goujard C; Lambotte O; Bourgeois C;
AIDS; 2019 Nov; 33(14):2137-2147. PubMed ID: 31688039
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.
Sáez-Cirión A; Sinet M; Shin SY; Urrutia A; Versmisse P; Lacabaratz C; Boufassa F; Avettand-Fènoël V; Rouzioux C; Delfraissy JF; Barré-Sinoussi F; Lambotte O; Venet A; Pancino G;
J Immunol; 2009 Jun; 182(12):7828-37. PubMed ID: 19494307
[TBL] [Abstract][Full Text] [Related]
8. HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood.
Hocini H; Bonnabau H; Lacabaratz C; Lefebvre C; Tisserand P; Foucat E; Lelièvre JD; Lambotte O; Saez-Cirion A; Versmisse P; Thiébaut R; Lévy Y
J Virol; 2019 May; 93(10):. PubMed ID: 30814287
[TBL] [Abstract][Full Text] [Related]
9. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
[TBL] [Abstract][Full Text] [Related]
10. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.
Guadalupe M; Sankaran S; George MD; Reay E; Verhoeven D; Shacklett BL; Flamm J; Wegelin J; Prindiville T; Dandekar S
J Virol; 2006 Aug; 80(16):8236-47. PubMed ID: 16873279
[TBL] [Abstract][Full Text] [Related]
11. Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.
Alatrakchi N; Duvivier C; Costagliola D; Samri A; Marcelin AG; Kamkamidze G; Astriti M; Agher R; Calvez V; Autran B; Katlama C
AIDS; 2005 Jan; 19(1):25-33. PubMed ID: 15627030
[TBL] [Abstract][Full Text] [Related]
12. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.
Steel A; John L; Shamji MH; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
HIV Med; 2008 Feb; 9(2):118-25. PubMed ID: 18257774
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of the T-cell receptor CD4 and CD8 V beta repertoire in HIV-1 vertically infected infants early treated with HAART.
Romiti ML; Cancrini C; Castelli-Gattinara G; Di Cesare S; Ciaffi P; Bernardi S; De Gasperi MR; Halapi E; Rossi P
AIDS; 2001 Nov; 15(16):2075-84. PubMed ID: 11684926
[TBL] [Abstract][Full Text] [Related]
14. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
[TBL] [Abstract][Full Text] [Related]
15. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
16. Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers.
Sáez-Cirión A; Hamimi C; Bergamaschi A; David A; Versmisse P; Mélard A; Boufassa F; Barré-Sinoussi F; Lambotte O; Rouzioux C; Pancino G;
Blood; 2011 Jul; 118(4):955-64. PubMed ID: 21642597
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy.
Potter SJ; Lemey P; Achaz G; Chew CB; Vandamme AM; Dwyer DE; Saksena NK
J Leukoc Biol; 2004 Sep; 76(3):562-70. PubMed ID: 15218056
[TBL] [Abstract][Full Text] [Related]
18. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
Guadalupe M; Reay E; Sankaran S; Prindiville T; Flamm J; McNeil A; Dandekar S
J Virol; 2003 Nov; 77(21):11708-17. PubMed ID: 14557656
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide expression profiling analysis to identify key genes in the anti-HIV mechanism of CD4
Gao L; Wang Y; Li Y; Dong Y; Yang A; Zhang J; Li F; Zhang R
J Med Virol; 2018 Jul; 90(7):1199-1209. PubMed ID: 29508932
[TBL] [Abstract][Full Text] [Related]
20. Elevated Expression of miR-19b Enhances CD8
Yin LB; Song CB; Zheng JF; Fu YJ; Qian S; Jiang YJ; Xu JJ; Ding HB; Shang H; Zhang ZN
Front Immunol; 2018; 9():3140. PubMed ID: 30687333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
